Brolucizumab for the treatment of diabetic macular edema.
Sign Up to like & getrecommendations! Published in 2022 at "Current opinion in ophthalmology"
DOI: 10.1097/icu.0000000000000849
Abstract: PURPOSE OF REVIEW To review the available data supporting the use of brolucizumab in the treatment of diabetic macular edema (DME). RECENT FINDINGS Brolucizumab is a humanized single- chain variable antibody fragment (scFv), the smallest… read more here.
Keywords: brolucizumab; macular edema; brolucizumab treatment; treatment ... See more keywords
[Short-term experience of intravitreal brolucizumab in treatment of diabetic macular edema].
Sign Up to like & getrecommendations! Published in 2023 at "Vestnik oftalmologii"
DOI: 10.17116/oftalma202313901199
Abstract: PURPOSE This study examines the efficacy and safety of brolucizumab in the treatment of diabetic macular edema (DME) in real clinical practice in the Russian Federation. MATERIAL AND METHODS The study included 14 consecutive treatment-naïve… read more here.
Keywords: macular edema; brolucizumab treatment; treatment; treatment diabetic ... See more keywords
Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies
Sign Up to like & getrecommendations! Published in 2022 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s378450
Abstract: Abstract Age-related macular degeneration (AMD), diabetic retinopathy and retinal vein occlusion represent some of the commonest degenerative conditions that lead to severe vision impairment in the developed countries. The gold standard treatment of complications associated… read more here.
Keywords: treatment degenerative; brolucizumab treatment; degenerative macular; macular conditions ... See more keywords